All
Results: 34297-34308 of 79105

New Potential Treatment Strategy for Brain Metastases and Leptomeningeal Disease: HER3-DXd Shows Promising Results in the Phase II TUXEDO-3 Study for Patients With Limited Therapeutic Options

Valmet changes its financial reporting structure aligned with new strategy and provides comparative segment information for 2024 and January-March 2025







